We are live on ! Find out more
HQL

abrdn Life Sciences Investors

75 hedge funds and large institutions have $118M invested in abrdn Life Sciences Investors in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 40 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 13

4% more capital invested

Capital invested by funds: $113M → $118M (+$4.75M)

0.72% less ownership

Funds ownership: 32.49%31.77% (-0.72%)

9% less funds holding

Funds holding: 8275 (-7)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
75
Holders Change
-7
Holders Change %
-8.54%
% of All Funds
0.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
40
Reduced
13
Closed
12
Calls
Puts
Net Calls
Net Calls Change

HQL Hedge Fund Activity: Q2 2025 in Review

75 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2025, worth a combined $118M — up 4.2% from $113M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of HQL and 5 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 40 added.

The largest buyer was Royal Bank of Canada, adding an estimated $4.66M. The largest seller was Absolute Investment Advisers, exiting entirely with an estimated $2.44M sold.

  • 75 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2025, down from 82 in Q1 2025.
  • Funds reported $118M of abrdn Life Sciences Investors stock for Q2 2025, up 4.2% quarter-over-quarter.
  • 5 funds opened new abrdn Life Sciences Investors positions in Q2 2025 and 12 closed out, a net change of -7 holders.
  • The largest abrdn Life Sciences Investors buyer in Q2 2025 was Royal Bank of Canada, an estimated $4.66M added.
  • The largest abrdn Life Sciences Investors seller in Q2 2025 was Absolute Investment Advisers, an estimated $2.44M sold.

Based on aggregated 13F filings for Q2 2025.